Shares of hVIVO plc (LON:HVO – Get Free Report) shot up 10% during trading on Monday . The company traded as high as GBX 22 ($0.27) and last traded at GBX 21.25 ($0.26). 7,804,669 shares were traded during mid-day trading, an increase of 164% from the average session volume of 2,961,263 shares. The stock had previously closed at GBX 19.33 ($0.24).
hVIVO Price Performance
The company has a market cap of £129.27 million, a price-to-earnings ratio of 633.33 and a beta of 0.97. The company has a current ratio of 1.61, a quick ratio of 1.16 and a debt-to-equity ratio of 33.86. The company has a fifty day moving average price of GBX 20.01 and a two-hundred day moving average price of GBX 25.58.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Featured Articles
- Five stocks we like better than hVIVO
- The Significance of Brokerage Rankings in Stock Selection
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- What Are Trending Stocks? Trending Stocks Explained
- 3 Steel Stocks Soaring After Tariff Announcements
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
